Lv11
60 积分 2025-03-03 加入
Fcγ receptors and immunomodulatory antibodies in cancer
11分钟前
待确认
Could immune checkpoints PD-1/PD-L1, PD-L2 and CTLA-4 be valuable in the spontaneous canine model of breast cancer?
1小时前
已完结
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
21天前
已完结
Efficacy, safety and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multi-center retrospective cohort study
21天前
已完结
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
26天前
已完结
Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study
1个月前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Breaking the hypoxia barrier: Advances and challenges of hyperbaric oxygen therapy in cancer treatment
1个月前
已完结
Hyperbaric oxygen targets RCN1 to modulate ER-mitochondria crosstalk and ameliorate sorafenib resistance in hepatocellular carcinoma
1个月前
已完结
Breaking the hypoxia barrier: Advances and challenges of hyperbaric oxygen therapy in cancer treatment
1个月前
已完结
皖公网安备34019202002308
